Therefore, the improvement in skin thickening after melatonin treatment in AD could be contributed to the combined effect of reduced keratinocyte proliferation, and regulation of chemotactic chemokines such as IP-10 and MCP-1. This evidence concerns the gene CCL2 and Alzheimer disease.